<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Elsberg JGD</submitter><funding>National Institutes of Health</funding><funding>NIGMS NIH HHS</funding><funding>National Science Foundation</funding><pagination>1712-1720</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8174646</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>50(5)</volume><pubmed_abstract>We report synthetic, structural and reactivity investigations of tris-(2-pyridylmethyl)amine (TPA)-ligated Cu(ii) 1,3-diketonate complexes. These complexes exhibit anaerobic retro-Claisen type C-C bond cleavage reactivity which exceeds that found in analogs supported by chelate ligands with fewer and/or weaker pyridyl interactions.</pubmed_abstract><journal>Dalton transactions (Cambridge, England : 2003)</journal><pubmed_title>Tris-(2-pyridylmethyl)amine-ligated Cu(II) 1,3-diketonate complexes: anaerobic retro-Claisen and dehalogenation reactivity of 2-chloro-1,3-diketonate derivatives.</pubmed_title><pmcid>PMC8174646</pmcid><funding_grant_id>P20 GM103546</funding_grant_id><funding_grant_id>P20GM103546</funding_grant_id><funding_grant_id>CHE-1429195</funding_grant_id><funding_grant_id>CHE-1664977</funding_grant_id><funding_grant_id>CHE-1828764</funding_grant_id><pubmed_authors>Elsberg JGD</pubmed_authors><pubmed_authors>Anderson SN</pubmed_authors><pubmed_authors>Berreau LM</pubmed_authors><pubmed_authors>Tierney DL</pubmed_authors><pubmed_authors>Reinheimer EW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Tris-(2-pyridylmethyl)amine-ligated Cu(II) 1,3-diketonate complexes: anaerobic retro-Claisen and dehalogenation reactivity of 2-chloro-1,3-diketonate derivatives.</name><description>We report synthetic, structural and reactivity investigations of tris-(2-pyridylmethyl)amine (TPA)-ligated Cu(ii) 1,3-diketonate complexes. These complexes exhibit anaerobic retro-Claisen type C-C bond cleavage reactivity which exceeds that found in analogs supported by chelate ligands with fewer and/or weaker pyridyl interactions.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Feb</publication><modification>2025-04-05T10:03:37.438Z</modification><creation>2025-04-05T10:03:37.438Z</creation></dates><accession>S-EPMC8174646</accession><cross_references><pubmed>33447836</pubmed><doi>10.1039/d0dt04074f</doi></cross_references></HashMap>